~~<i id='40DF79239F'><strike id='40DF79239F'><tt id='40DF79239F'><pre id='40DF79239F'></pre></tt></strike></i>~~

Home» explore» focus

focus

author：comprehensive 2025-09-28 11:47:08 Page View：4

Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send us a note: kate.she[email protected]. Your experience might make a future column.

Who we talked to:

Lily Ting, 35. Associate, PureTech Health, Boston. Head of R&D, Commense, Boston. Expert, protein-protein interactions. Expert, human-human interactions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： EMA weighs against approval for Mirati's lung cancer drug
Next article： At least 13 dead in Texas as scorching temps continue

explore

Psychedelics group wrestles with new pharma identity

OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

North Korean leader's powerful sister says warplanes repelled US spy plane

FILE-KimYoJong,sisterofNorthKorea'sleaderKimJongUn,attendsawreath-layingceremonyatHoChiMinhMausoleum

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

What to know about a major upcoming Wegovy heart health study

AdobeAtsomepointthissummer,thedrugmakerNovoNordiskwillreleaseresultsfromacloselywatchedstudythat,ifs